MANDEVILLE – Water purification company MECO has been ramping up production of systems required in biopharmaceutical research and development as global biopharmaceutical companies race to create the first COVID-19 vaccine.
For more than 90 years, MECO has provided water purification systems to industries around the world. MECO water is used by pharmaceutical and biotechnology companies for the manufacturing of medical devices, diagnostics, vaccines, generic medicines, and nutritional products. Today, biopharmaceutical companies use these types of water purification systems to produce massive volumes of purified water, water for injection and pure steam to develop medication, manufacture IV fluid, sterilize product packaging and produce COVID-19 tests.
“Our priority is to work together and do all that we can to provide our customers with the high purity water that is critical to the development and manufacturing of life-saving medications now and for future generations,” said George Gsell, MECO president. MECO remains diligent in supporting its customers by supplying the necessary water purification systems while implementing the safety protocols provided by the CDC and the WHO to ensure the health and well-being of all employees, community members and company operations.
Click here for more information.
The post Northshore Company’s High Purity Water Systems Aid Vaccine Development appeared first on Biz New Orleans.